Galectin Therapeutics Inc. Share Price
GALTGalectin Therapeutics Inc. Stock Performance
Open $3.81 | Prev. Close $3.45 | Circuit Range N/A |
Day Range $3.35 - $3.81 | Year Range $1.07 - $7.13 | Volume 54,526 |
Average Traded $3.61 |
Galectin Therapeutics Inc. Share Price Chart
About Galectin Therapeutics Inc.
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in Phase 2b/3 clinical trial to prevent esophageal varices in patient with non-alcoholic steatohepatitis cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and head and neck squamous cell carcinoma. Galectin Therapeutics Inc. has a collaborative joint venture co-owned by SBH Sciences, Inc. with Galectin Sciences, LLC for the research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Galectin Therapeutics Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Jan-26 | $3.81 | $3.44 | +0.00% |
06-Jan-26 | $3.81 | $3.44 | -11.34% |
05-Jan-26 | $4.00 | $3.88 | -3.72% |
02-Jan-26 | $4.22 | $4.03 | -2.89% |
31-Dec-25 | $4.08 | $4.15 | +1.47% |
30-Dec-25 | $4.05 | $4.09 | +0.25% |
29-Dec-25 | $4.04 | $4.08 | +0.99% |
FAQs on Galectin Therapeutics Inc. Share Price
Can I buy Galectin Therapeutics Inc. shares in India?
What is the share price of Galectin Therapeutics Inc.?
What is the 5 year returns of Galectin Therapeutics Inc.?
What are the high & low stock price of Galectin Therapeutics Inc. today?
What is the 52-week high and low of Galectin Therapeutics Inc. stock?